CED-6 Inhibitors
CED-6 Inhibitors are a class of compounds that inhibit the expression or activity of the CED-6 protein. CED-6 is a protein that plays a critical role in programmed cell death, or apoptosis. CED-6 is a caspase, which are enzymes that execute the final steps of apoptosis by cleaving and activating other proteins that lead to the dismantling of the cell.
CED-6 Inhibitors exert their effect by modulating different aspects of CED-6 biology. Some CED-6 Inhibitors, such as small molecule inhibitors, can directly bind to CED-6 and prevent it from interacting with its substrates or from being activated. Other CED-6 Inhibitors, such as gene silencing agents (e.g., siRNA, shRNA), can reduce the expression of CED-6 mRNA or protein. By modulating CED-6 expression or activity, CED-6 Inhibitors can influence apoptosis and cell death. These compounds could potentially be used to study the role of CED-6 in various diseases and conditions, such as cancer and neurodegenerative disorders.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
A component of the outer membrane of Gram-negative bacteria that activates the NF-κB signaling pathway, leading to increased CED-6 expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
A glucocorticoid that activates the glucocorticoid receptor, leading to increased CED-6 expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A vitamin A derivative that activates the retinoic acid receptor, leading to increased CED-6 expression. | ||||||